Bearish
3
Neutral
8
Bullish
3
Bearish
20
Neutral
12
Bullish
14
Bearish
17
Neutral
4
Bullish
11
Investor Presentation
Q2 FY26
Investor Presentation
Q4 FY25
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.


Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Performance
STEADY PERFORMER
Valuation
REASONABLE
Growth
EXCEPTIONAL
Profitability
MODERATE MARGIN
Technicals
Bearish
Risk
MODERATE RISK
Healthcare
Diagnostic Services
719 Cr
Low Risk
32.4
48.3
0.7
5.9
358.00
140.00
Sales CAGR
1Y
30.31%
3Y
21.73%
5Y
14.18%
10Y
—
Profit CAGR
1Y
43.77%
3Y
—
5Y
70.91%
10Y
—
ROE
TTM
19.63%
3Y
21.72%
5Y
17.10%
10Y
—
ROCE
TTM
21.52%
3Y
25.56%
5Y
21.71%
10Y
—
Market Cap
₹ 719 Cr
P/E
32.40
Press Release
1 day ago
Chandan Healthcare Secures 10-Year PPP Project
Chandan Healthcare Limited has been awarded a 10-year Public Private Partnership project to develop and operate advanced radiology centres in Punjab, enhancing diagnostic services with an estimated cost of ₹26 crore.
Analyst/Investor Meet
5 days ago
Chandan Healthcare Analyst Meeting Scheduled
Chandan Healthcare Limited announces a scheduled virtual meeting with analysts and institutional investors set for December 16, 2025, to discuss company updates.